M
Mona Abdalla
Researcher at University of London
Publications - 17
Citations - 3721
Mona Abdalla is an academic researcher from University of London. The author has contributed to research in topics: Misoprostol & Postoperative nausea and vomiting. The author has an hindex of 13, co-authored 17 publications receiving 3567 citations.
Papers
More filters
Journal ArticleDOI
A factorial trial of six interventions for the prevention of postoperative nausea and vomiting.
Christian C. Apfel,Christian C. Apfel,Kari Korttila,Mona Abdalla,Heinz Kerger,Alparslan Turan,Ina Vedder,Carmen Zernak,Klaus Danner,Ritva Jokela,Stuart J. Pocock,Stefan Trenkler,Markus Kredel,Andreas Biedler,Daniel I. Sessler,Norbert Roewer +15 more
TL;DR: Ondansetron, dexamethasone, and droperidol each reduced the risk of postoperative nausea and vomiting by about 26 percent, and the safest or least expensive antiemetic interventions should be used first.
Journal ArticleDOI
Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial*
Ferenc Follath,John G.F. Cleland,Hanjörg Just,Julius Gy. Papp,H. Scholz,K. Peuhkurinen,Veli-Pekka Harjola,Veselin Mitrovic,Mona Abdalla,E.P. Sandell,Lasse Lehtonen +10 more
TL;DR: In patients with severe, low-output heart failure, levosimendan improved haemodynamic performance more effectively than dobutamine and was accompanied by lower mortality in the levosIMendan group than in theDobutamine group for up to 180 days.
Journal ArticleDOI
Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol.
TL;DR: A prospective, randomized trial to compare oral with vaginal administration of the prostaglandin E1 analogue misoprostol for first-trimester abortion in women treated initially with mifepristone in women seeking abortion within 63 days after the onset of amenorrhea.
Steering committee and investigators of the levosimendan infusion versus dobutamine (lido) study. efficacy and safety of intravenous levosimendan compared with dobutamine in severe lowoutput heart failure (the lido study): a randomised doubleblind trial
F. Follath,John G.F. Cleland,H. Just,Julius Gy. Papp,H. Scholz,K. Peuhkurinen,V P Harjola,Veselin Mitrovic,Mona Abdalla,E P Sandell,L Lehtonen +10 more
Journal ArticleDOI
Ketorolac, diclofenac, and ketoprofen are equally safe for pain relief after major surgery.
J. B. Forrest,F. Camu,I. A. Greer,Henrik Kehlet,Mona Abdalla,Fabrice Bonnet,Shah Ebrahim,G. Escolar,J. Jage,Stuart J. Pocock,Giampaolo Velo,M. J. S. Langman,G. Bianchi Porro,M. M. Samama,E. Heitlinger +14 more
TL;DR: It is concluded that ketorolac is as safe as ketoprofen and diclofenac for the treatment of pain after major surgery.